Stay updated with breaking news from Karuna Kar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Significant operational and clinical progress in 2023 and early 2024 with maturation of Internal Programs,1 launch of two new Founded Entities,2 including a $100 million Series A financing for...
Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech.
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma First Quarter Earnings Conference Call.
The biotech sector is down this year, but these two biopharmaceutical stocks have delivered strong returns.